fficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trial

艾司西酞普兰与帕罗西汀-CR 在日本重度抑郁症患者中的疗效和耐受性：一项随机、盲测试验

• 批准号: 25861033
• 负责人: KISHI Taro
• 金额: $ 2.66万
• 依托单位: Fujita Health University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Young Scientists (B)
• 财政年份: 2013
• 资助国家: 日本
• 起止时间: 2013-04-01 至 2015-03-31
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25861033/
• 关键词: 大うつ病性障害; エスシタロプラム; パロキセチン徐放製剤; 効果; 安全性; 大うつ病性障害と; 無作為割付試験

项目成果

Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.

• DOI: 10.1371/journal.pone.0088049
• 发表时间: 2014
• 期刊: PloS one
• 影响因子: 3.7
• 作者: Kishi T;Matsuda Y;Iwata N
• 通讯作者: Iwata N

Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: a meta-analysis of double-blind randomized placebo-controlled trials.

去甲肾上腺素再摄取抑制剂增强治疗精神分裂症的疗效和安全性：双盲随机安慰剂对照试验的荟萃分析。

• DOI: 10.1016/j.jpsychires.2013.07.003
• 发表时间: 2013
• 期刊: J Psychiatr Res
• 影响因子: 4.8
• 作者: Kishi T;Mukai T;Matsuda Y;Moriwaki M;Iwata N.
• 通讯作者: Iwata N.

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials.

• DOI: 10.2147/ndt.s78977
• 发表时间: 2015
• 期刊: Neuropsychiatric disease and treatment
• 影响因子: 3.2
• 作者: Kishi T;Matsuda Y;Matsunaga S;Iwata N
• 通讯作者: Iwata N